@article{medri:8557,
	author = {{Lucijanić, Marko and Krečak, Ivan and Sorić, Ena and Sabljić, Anica and Galušić, Davor and Holik, Hrvoje and Periša, Vlatka and Morić Perić, Martina and Zekanović, Ivan and Budimir, Josipa and Kušec, Rajko}},
	title = {{Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis}},
}
@article{medri:8548,
	author = {{Papić, Ivan and Bistrović, Petra and Krečak, Ivan and Ortner Hadžiabdić, Maja and Lucijanić, Marko}},
	title = {{Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use}},
}
@article{medri:8544,
	author = {{Lucijanić, Marko and Krečak, Ivan and Sorić, Ena and Sabljić, Anica and Vasilj, Tamara and Cicic, David and Vrkljan Vuk, Anamarija and Kremer, Zvonimir and Dilber, Ivo and Glasnović, Anton and Jakšić, Ozren and Kušec, Rajko}},
	title = {{Secondary polycythemia in acutely ill COVID-19 patients is associated with higher mortality but not markedly higher thrombotic risk}},
}
@article{medri:8523,
	author = {{Krečak, Ivan and Leković, Danijela and Arsenović, Isidora and Holik, Hrvoje and Zekanović, Ivan and Morić Perić, Martina and Lucijanić, Marko}},
	title = {{The triple A model (age, absolute neutrophil count, absolute lymphocyte count‐ AAA ) predicts survival and thrombosis in polycythemia vera}},
}
@article{medri:8428,
	author = {{Aurer, Igor and Jakšić, Ozren and Bašić-Kinda, Sandra and Mrđenović, Stefan and Ostojić-Kolonić, Slobodanka and Lozić, Dominik and Holik, Hrvoje and Novaković-Coha, Sabina and Berneš, Petra and Krečak, Ivan and Morić-Perić, Martina and Narančić, Marino and Mitrović, Zdravko and Valković, Toni}},
	title = {{Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases}},
}
@article{medri:8447,
	author = {{Krečak, Ivan and Leković, Danijela and Grohovac, Dragana and Sabljić, Anica and Holik, Hrvoje and Zekanović, Ivan and Morić Perić, Martina and Galušić, Davor and Periša, Vlatka and Krečak, Filip and Skelin, Marko and Lucijanić, Marko}},
	title = {{Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia}},
}
@article{medri:8265,
	author = {{Krečak, Ivan and Vestovšek, Srđan and Lucijanić, Marko}},
	title = {{Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms}},
}
@article{mef:9547,
	author = {{Krečak, Ivan and Verstovsek, Srdan and Lucijanić, Marko}},
	title = {{Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms}},
}
@article{mef:9549,
	author = {{Krečak, Ivan and Verstovsek, Srdan and Lucijanić, Marko}},
	title = {{Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives}},
}
@article{medri:8290,
	author = {{Krečak, Ivan and Lucijanić, Marko}},
	title = {{Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia}},
}
@article{mef:9398,
	author = {{Krečak, Ivan and Lucijanić, Marko}},
	title = {{Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia}},
}
@article{medri:8294,
	author = {{Lucijanić, Marko and Krečak, Ivan and Cicic, David and Milošević, Marko and Vukoja, Damir and Kovačević, Ivona and Marasović, Ivan and Sedinić Lacko, Martina and Baković, Josip and Jonjić, Zeljko and Vasilj, Tamara and Stojić, Josip and Atic, Armin}},
	title = {{Hypoosmolar and hyperosmolar COVID-19 patients are predisposed to dismal clinical outcomes}},
}
@article{medri:8287,
	author = {{Lucijanić, Marko and Krečak, Ivan}},
	title = {{Pulmonary embolism, is it healthy to be volume expanded?}},
}
@mastersthesis{medri:7935,
	author = {{Bačić, Josipa Antonija}},
	title = {{Potencijalne interakcije lijekova u bolesnika oboljelih od nealkoholne masne bolesti jetre}},
}
@article{medri:7728,
	author = {{Holik, Hrvoje and Krečak, Ivan and Lucijanić, Marko and Samardžić, Ivan and Pilipac, Danijel and Vučinić Ljubičić, Ivana and Coha, Božena and Kitter Pipić, Alma and Miškić, Blaženka and Zupančić-Šalek, Silva}},
	title = {{Hip and Knee Osteoarthritis in Patients with Chronic Myeloproliferative Neoplasms: A Cross-Sectional Study}},
}
@article{medri:7581,
	author = {{Krečak, Ivan and Pivac, Ljerka and Lucijanić, Marko and Skelin, Marko}},
	title = {{Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms}},
}
@article{mef:6724,
	author = {{Krečak, Ivan and Pivac, Ljerka and Lucijanić, Marko and Skelin, Marko}},
	title = {{Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms}},
}
@article{medri:8277,
	author = {{Krečak, Ivan and Šupe, Marijana and Petričević Krečak, Ojdana}},
	title = {{The great mimicker of dural pathology: primary dural diffuse large B-cell lymphoma}},
}
@article{medri:8016,
	author = {{Krečak, Ivan and Zekanović, Ivan and Morić Perić, Martina and Holik, Hrvoje and Coha, Božena and Periša, Vlatka and Lucijanić, Marko}},
	title = {{High plateletcrit may be associated with thrombotic risk in polycythemia vera}},
}
@article{medri:8013,
	author = {{Krečak, Ivan and Skelin, Marko and Verstovsek, Srdan}},
	title = {{Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera}},
}
@article{medri:7584,
	author = {{Krečak, Ivan and Čeko, Monika and Nižetić, Karla and Čubrić, Eva and Županović, Mediana and Skelin, Marko and Lucijanić, Marko}},
	title = {{Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism}},
}
@article{medri:7632,
	author = {{Krečak, Ivan and Grohovac, Dragana and Vučenović Bašić, Nikolina and Čeko, Monika and Nižetić, Karla and Sabljić, Anica and Holik, Hrvoje and Galušić, Davor and Zekanović, Ivan and Morić Perić, Martina and Periša, Vlatka and Lucijanić, Marko}},
	title = {{Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms}},
}
@article{medri:7583,
	author = {{Lucijanić, Marko and Krečak, Ivan and Sorić, Ena and Galušić, Davor and Holik, Hrvoje and Periša, Vlatka and Morić Perić, Martina and Zekanović, Ivan and Kušec, Rajko}},
	title = {{Palpable spleen size is differently prognostic in primary and secondary myelofibrosis}},
}
@article{medri:7582,
	author = {{Lucijanic, Marko and Krečak, Ivan}},
	title = {{Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms}},
}
@article{medri:8017,
	author = {{Lucijanić, Marko and Krečak, Ivan and Sorić, Ena and Sabljić, Anica and Galušić, Davor and Holik, Hrvoje and Periša, Vlatka and Perić, Martina Morić and Zekanović, Ivan and Kušec, Rajko}},
	title = {{Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis}},
}
@article{medri:8129,
	author = {{Krečak, Ivan and Gverić-Krečak, Velka}},
	title = {{Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab}},
}
@article{medri:7415,
	author = {{Čubrić, Eva and Kinkela, Matilda and Stipaničev, Anamarija and Skorić, Ivana and Kušpilić Papak, Iris and Krečak, Ivan}},
	title = {{Refraktorna krvarenja iz multiplih angiodisplazija crijeva uspješno liječena talidomidom}},
}
@article{medri:7578,
	author = {{Krečak, Ivan and Holik, Hrvoje and Morić Perić, Martina and Zekanović, Ivan and Coha, Božena and Lucijanić, Marko}},
	title = {{Chronic Kidney Disease has a Higher Prevalence in Polycythemia Vera than in Secondary Polycythemia, a Matched Case–Control Analysis}},
}
@article{medri:7577,
	author = {{Bručić, Lana Jajac and Krečak, Ivan}},
	title = {{Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone}},
}
@article{medri:6989,
	author = {{Krečak, Ivan and Nižetić, Karla and Čeko, Monika and Skelin, Marko and Lucijanić, Marko}},
	title = {{Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism}},
}
@article{medri:6988,
	author = {{Krečak, Ivan and Skorić, Ivana and Čengić, Marina and Krečak, Filip and Skelin, Marko}},
	title = {{Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim}},
}
@article{medri:6994,
	author = {{Krečak, Ivan and Lucijanić, Marko and Verstovšek, Srđan}},
	title = {{Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia}},
}
@article{mef:5035,
	author = {{Lucijanić, Marko and Krečak, Ivan and Sorić, Ena and Sabljic, Anica and Galušić, Davor and Holik, Hrvoje and Periša, Vlatka and Morić Perić, Martina and Zekanović, Ivan and Kušec, Rajko}},
	title = {{Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis}},
}
@article{medri:6996,
	author = {{Lucijanić, Marko and Krečak, Ivan and Soric, Ena and Sabljić, Anica and Galusic, Davor and Holik, Hrvoje and Periša, Vlatka and Morić Perić, Martina and Zekanović, Ivan and Kušec, Rajko}},
	title = {{Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis}},
}
@article{medri:7001,
	author = {{Čubrić, Eva and Šupe, Marijana and Krečak, Ivan}},
	title = {{Persistent fever, bloody diarrhea, and skin necrosis in a young female}},
}
@article{mef:4965,
	author = {{Lucijanić, Marko and Jurin, Ivana and Sedinić Lacko, Martina and Sorić, Ena and Sabljić, Anica and Krečak, Ivan and Mitrović, Joško and Marelić, Daniela and Kremer, Zvonimir and Hadžibegović, Irzal and Lucijanić, Tomo and Kušec, Rajko}},
	title = {{Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients}},
}
@article{medri:7002,
	author = {{Krečak, Ivan and Celić-Bunikić, Sandra and Skelin, Marko and Lucijanić, Marko and Verstovsek, Srdan and Kušec, Rajko}},
	title = {{Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate}},
}
@article{medri:6962,
	author = {{Krečak, Ivan and Lucijanić, Marko}},
	title = {{Can we use platelet-to-lymphocyte ratio (PLR) to differentiate JAK2-unmutated erythrocytosis from polycythemia vera?}},
}
@article{medri:7000,
	author = {{Lucijanić, Marko and Krečak, Ivan and Soric, Ena and Sabljic, Anica and Galušić, Davor and Holik, Hrvoje and Periša, Vlatka and Perić, Martina Morić and Zekanović, Ivan and Kušec, Rajko}},
	title = {{MPN-541 Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks}},
}
@article{medri:6995,
	author = {{Krečak, Ivan and Babić, Gordan and Skelin, Marko}},
	title = {{Scurvy}},
}
@article{medri:6991,
	author = {{Krečak, Ivan and Rončević, Pavle and Kursar, Marin and Lucijanić, Marko and Galušić, Davor and Mrđenović, Stefan and Morić Perić, Martina and Ivanko, Iva and Matijaca, Hana and Budimir, Josipa and Jakelić, Sanja and Karaman, Ivana and Kušec, Rajko}},
	title = {{Sistemska mastocitoza u Republici Hrvatskoj}},
}
@article{mef:5231,
	author = {{Krečak, Ivan and Rončević, Pavle and Kursar, Marin and Lucijanić, Marko and Galušić, Davor and Mrđenović, Stefan and Morić Perić, Martina and Ivanko, Iva and Matijaca, Hana and Budimir, Josipa and Jakelić, Sanja and Karaman, Ivana and Kušec, Rajko}},
	title = {{Sistemska mastocitoza u Republici Hrvatskoj}},
}
@article{mef:4178,
	author = {{Lucijanić, Marko and Krečak, Ivan and Sorić, Ena and Sedinić, Martina and Sabljić, Anica and Derek, Lovorka and Jakšić, Ozren and Kušec, Rajko}},
	title = {{Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism}},
}
@article{medri:6990,
	author = {{Krečak, Ivan and Lucijanić, Marko and Gverić-Krečak, Velka and Duraković, Nadira}},
	title = {{Hyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera}},
}